Cadonilimab is efficacious in HER2-negative advanced-stage G/GEJ adenocarcinomas
1Nature Reviews Clinical Oncology, . Diana.Romero@nature.com.
Nature Reviews. Clinical Oncology
|February 7, 2025
Abstract
No abstract available in PubMed .
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
10.9K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.7K
